Coronavirus Update: Sotrovimab Filed For EUA In Japan

Plus, Korea Sets Up mRNA Consortium

GSK could soon see an approval in Japan for its antibody therapy following a filing for emergency use, while South Korea looks to build its mRNA vaccine capabilities through a new consortium. 

Covid antibody therapy
antibody therapies gain Japan momentum • Source: Alamy

More from COVID-19

More from Scrip